Dietary Supplements Access Act
SB 4587, the Dietary Supplements Access Act, would amend the Internal Revenue Code to treat certain dietary supplement purchases as qualified medical expenses for tax-favored health accounts. Specifically, it would allow amounts paid for dietary supplements to be treated as medical care for purposes of Health Savings Accounts (HSAs), Archer MSAs, and health flexible spending arrangements/health reimbursement arrangements (FSAs/HRAs), subject to an annual cap of $500 per taxpayer, or $250 for a married individual filing separately.
The bill defines dietary supplements by reference to the Federal Food, Drug, and Cosmetic Act, but excludes products marketed, labeled, or commonly understood to be energy drinks, soft drinks, or soda. The changes would apply to amounts paid or expenses incurred after December 31, 2026, giving taxpayers and plan administrators time to adjust. In practical terms, the bill would expand the range of health-related purchases eligible for tax-preferred reimbursement and distribution under existing federal tax rules.
The bill would amend sections 223, 220, 106, and 105 of the Internal Revenue Code to add dietary supplements as eligible medical expenses within specified limits. This would affect taxpayers who use HSAs, Archer MSAs, FSAs, and HRAs, as well as employers, plan administrators, and financial institutions that administer these accounts. It would not create a new benefit program, but would change federal tax treatment for certain out-of-pocket supplement purchases beginning in tax years after 2026.
There is limited recorded debate or voting history available for SB 4587, so no clear partisan or committee sentiment can be inferred from transcripts or roll calls. Based on the bill’s introduction and referral, the measure appears to have been presented as a consumer-access and tax-relief proposal for health-related purchases. The absence of recorded opposition or support in the provided materials means the overall sentiment is best characterized as neutral and undeveloped at this stage.
The main policy issue is whether dietary supplements should be treated like medical care for tax purposes. Supporters are likely to argue that supplements are commonly used for health and wellness and should be eligible for HSA/FSA reimbursement, while critics may question the medical necessity of supplements, the revenue cost of the tax exclusion, and the potential for abuse or overbroad claims. The bill addresses one likely concern by excluding energy drinks, soft drinks, and soda, but the definition and scope of eligible products could still be a point of contention.